TPG agrees to buy generic drugmaker Par for $1.9 bln

July 16 (Reuters) - Private equity firm TPG said on Monday
it would acquire U.S.-based Par Pharmaceutical Cos Inc
for $1.9 billion in the latest acquisition in the generic drug
industry.

i have a structured settlement and i need cash now buying a structured settlement buying structured settlements